Showing results (1291-1300 of 1,653) with videos related to
Sort By:
Pageof 166
Scientific Reports|April 22, 2022
Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling dataLillian R Thistlethwaite, Xiqi Li, Lindsay C Burrage, et al.Pharmacogenetics|August 1, 1996
Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary reportK Blum, E R Braverman, R C Wood, et al.JAMA|March 8, 1995
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid AssociationP A Singer, D S Cooper, E G Levy, et al.Pain Medicine (Malden, Mass.)|April 22, 2004
Etiologies of failed back surgery syndromeCurtis W Slipman, Carl H Shin, Rajeev K Patel, et al.Journal of Magnetic Resonance Imaging : JMRI|August 28, 2004
Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imagingLidia M Nagae-Poetscher, Michael McMahon, Nancy Braverman, et al.International Journal of Environmental Research and Public Health|May 14, 2022
Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis"Eric R Braverman, Catherine A Dennen, Mark S Gold, et al.American Journal of Surgery|August 21, 2024
An analysis of the effect of low titer O whole blood (LTOWB) proportions for resuscitation after trauma on 6-hour and 24-hour survivalAndrew D Fisher, Michael D April, Mark H Yazer, et al.Journal of the American Academy of Dermatology|April 26, 2006
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosisRobert M Knobler, Lars E French, Youn Kim, et al.Allergy and Asthma Proceedings|May 17, 2025
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedemaMar Guilarte, William R Lumry, Markus Magerl, et al.Oncogene|February 15, 2001
The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitinationG Benvenuto, S Li, S J Brown, et al.Pageof 166